Esther McVey

Esther McVey

Conservative — Tatton

Speaking in the House of Commons on 17 November 2026

Debate

Medicines and Healthcare Products Regulatory Agency

Contribution

My hon. Friend has put that important point on the record; I know other people will speak to that today. It is yet another finding about the inadequacy of the agency. Finally, will the Minister for Health Innovation, who jointly launched and endorsed the MHRA strategy 2030 last month, attend the meeting that I have with the Minister for Public Health and Patient Safety, who has agreed to a meeting with me and the family of my former constituent? Or can he commit to a further meeting without delay? The performance of the MHRA in this case fell short of what we should expect. I feel sure the Minister will want to do the right thing and learn from that case to help to protect future patients from such devastating harm.

More from Esther McVey

Other recent Hansard contributions by the same speaker.

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.

For Esther McVey's full parliamentary record including voting history, expenses and all other contributions, see the Esther McVey report card.